Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGfinity Regulatory News (GFIN)

Share Price Information for Gfinity (GFIN)

Share Price is delayed by 15 minutes
Get Live Data
0.055    0.009 (19.57%)
Bid:
0.05
Ask:
0.06
Spread: 0.01 (20.00%)
Market Cap: £2.44m
GFIN Live PriceLast checked at - London Stock Exchange

Intraday Gfinity Share Chart

Correction: Form 8.3 - Gfinity plc

13 Jan 2021 09:44

RNS Number : 5386L
Gfinity PLC
13 January 2021
Β 

Amendment - this form replaces RNS: 1168D. Changes made to Section 2a.

Β 

FORMΒ 8.3Β 

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYΒ Β 

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MOREΒ 

Rule 8.3Β of the Takeover Code (the "Code")Β 

Β 

1.KEY INFORMATIONΒ 

Β 

(a)Full name ofΒ discloser:Β 

John Edward StoryΒ 

(b)Owner or controller of interests and short positions disclosed, if different from 1(a):Β 

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.Β 

(c)Name of offeror/offeree in relation to whose relevant securitiesΒ this formΒ relates:Β 

Use a separate form for each offeror/offereeΒ 

GfinityΒ PlcΒ 

(d)If an exempt fund manager connected with an offeror/offeree, state this and specifyΒ identity ofΒ offeror/offeree:Β 

(e)Date position held/dealing undertaken:Β 

For an opening position disclosure,Β stateΒ the latestΒ practicable date prior to the disclosureΒ 

19thΒ October 2020Β 

(f)In addition to the company in 1(c) above, is the discloserΒ making disclosuresΒ in respect of anyΒ otherΒ party to the offer?Β 

If it is aΒ cashΒ offerΒ or possible cash offer, state "N/A"Β 

N/AΒ 

If YES, specify which:Β 

Β 

2.POSITIONS OF THE PERSON MAKING THE DISCLOSUREΒ 

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.Β 

Β 

(a)Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealingΒ (if any)Β 

Β 

Class of relevant security:Β 

Β 

OrdinaryΒ Shares 0.1pΒ Β 

Β 

Β 

InterestsΒ 

Short positionsΒ 

NumberΒ 

%Β 

NumberΒ 

%Β 

(1)RelevantΒ securities owned and/or controlled:Β 

30,000,000Β 

3.88Β 

(2)Cash-settled derivatives:Β 

Β 

Β 10,000,000

1.29Β 

(3)Stock-settled derivatives (including options)Β and agreements to purchase/sell:Β 

Β 

TOTAL:Β 

40,000,000Β 

5.18Β 

Β 

AllΒ interests andΒ allΒ short positions should be disclosed.Β 

Β 

Details of any openΒ stock-settledΒ derivativeΒ positionsΒ (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Formβ€―8 (Open Positions).Β 

Β 

(b)Rights to subscribeΒ for new securities (including directors' and otherΒ employeeΒ options)Β 

Β 

Class of relevant securityΒ in relation to which subscription right exists:Β 

Ordinary Share 0.1pΒ 

Details, including nature of the rights concerned and relevant percentages:Β 

Warrants to subscribe for 40,000,000 ordinary shares at 1p with an expiry date 23rdΒ October 2021Β 

Β 

Β 

3. DEALINGSΒ (IF ANY) BY THE PERSON MAKING THE DISCLOSUREΒ 

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.Β 

Β 

The currency of all prices and other monetary amounts should be stated.Β 

Β 

(a) Purchases and salesΒ 

Β 

Class of relevant securityΒ 

Purchase/saleΒ 

Β 

Number of securitiesΒ 

Price per unitΒ 

Β 

Β 

Β 

(b) Cash-settled derivative transactionsΒ 

Β 

Class of relevant securityΒ 

Product descriptionΒ 

e.g.Β CFDΒ 

Nature ofΒ dealingΒ 

e.g.Β opening/closing aΒ long/short position, increasing/reducingΒ aΒ long/short positionΒ 

Number ofΒ referenceΒ securitiesΒ 

Price per unitΒ 

Β 

Β 

Β 

(c) Stock-settled derivativeΒ transactionsΒ (including options)Β 

Β 

(i) Writing, selling, purchasing or varyingΒ 

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

Β 

(ii) ExerciseΒ 

Β 

Class of relevant securityΒ 

Product descriptionΒ 

e.g.Β call optionΒ 

Exercising/ exercised againstΒ 

Number of securitiesΒ 

Exercise price per unitΒ 

Β 

Β 

Β 

(d) Other dealings (includingΒ subscribing forΒ new securities)Β 

Β 

Class of relevant securityΒ 

Nature ofΒ dealingΒ 

e.g.Β subscription, conversionΒ 

DetailsΒ 

Price per unit (if applicable)Β 

Β 

Β 

Β 

Β 

4. OTHER INFORMATIONΒ 

Β 

(a) Indemnity and other dealing arrangementsΒ 

Β 

Details of anyΒ indemnity or optionΒ arrangement,Β orΒ any agreement orΒ understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealingΒ entered intoΒ by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Β 

Irrevocable commitments and letters of intent shouldΒ notΒ be included. IfΒ there are no such agreements, arrangements or understandings, state "none"Β 

Β 

noneΒ 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivativesΒ 

Β 

Details of any agreement, arrangement or understanding, formal or informal,Β between the personΒ making the disclosureΒ and any other person relating to:Β 

(i)the voting rights of any relevant securities under any option;Β orΒ Β 

(ii)the voting rights or future acquisition or disposal of any relevant securities to which any derivativeΒ is referenced:Β 

If there are no such agreements, arrangements or understandings, state "none"Β 

Β 

Β 

noneΒ 

Β 

(c) AttachmentsΒ 

Β 

Is aΒ Supplemental Form 8 (Open Positions)Β attached?Β 

NOΒ 

Β 

Β 

Date of disclosure:Β 

6 January 2021Β 

Contact name:Β 

John E StoryΒ 

Telephone number*:Β 

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.Β 

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.Β 

Β 

*If the discloser is a naturalΒ person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.Β 

Β 

The Code can be viewed on the Panel's website atΒ www.thetakeoverpanel.org.uk.Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETKXLBFFFLXBBL
Date   Source Headline
23rd Mar 20267:00 amRNSHalf-year Financial Report
24th Feb 20265:46 pmRNSHolding(s) in Company
20th Feb 20263:30 pmRNSAward of share options
9th Jan 20264:31 pmRNSResult of AGM
22nd Dec 20257:00 amRNSHolding(s) in Company
22nd Dec 20257:00 amRNSHolding(s) in Company
17th Dec 20254:45 pmRNSFinal Results and Notice of AGM
8th Dec 20252:55 pmRNSHolding(s) in Company
26th Nov 20251:05 pmRNSResult of Meeting
11th Nov 202511:05 amRNSProposed Fundraising and Notice of General Meeting
16th Sep 20253:36 pmRNS-RYentra Announces Collaboration with ESG Institute
8th Sep 20257:00 amRNS-RYentra.AI and TTRO Announce Strategic Partnership
2nd Sep 202511:46 amRNSCorporate update
7th May 20257:00 amRNSIssue of Equity
2nd May 20257:00 amRNSCorporate update
19th Mar 20252:25 pmRNSHalf-year Report
5th Mar 20253:41 pmRNSHolding(s) in Company
14th Feb 20254:02 pmRNSDirector/PDMR Shareholding
5th Feb 20255:00 pmRNSIssue of Equity
5th Feb 202511:08 amRNSNew business development and funding
31st Jan 20252:25 pmRNSResult of Meeting
16th Jan 20255:00 pmRNSNotice of GM
13th Jan 20251:15 pmRNSRestoration of trading
13th Jan 20251:15 pmRNSRestoration - Gfinity plc
13th Jan 20257:00 amRNSFinal Results
2nd Jan 20257:30 amRNSSuspension - Gfinity plc
18th Dec 20245:00 pmRNSResult of AGM, Accounts and trading update
22nd Nov 20242:00 pmRNSNotice of AGM
11th Nov 20242:35 pmRNSNew business development and trading update
7th Oct 20247:00 amRNSDirector/PDMR Shareholding
26th Sep 20243:00 pmRNSDirector/PDMR Shareholding
26th Sep 202411:15 amRNSTrading update and funding
3rd Jul 20245:48 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSHalf-year Report
14th Feb 20242:38 pmRNSResult of meeting and change of registered office
30th Jan 20248:50 amRNSNotice of GM
22nd Dec 20237:00 amRNSFinal Results
21st Dec 20235:35 pmRNSResult of AGM
5th Dec 20237:00 amRNSDisposal
27th Nov 20237:00 amRNSDisposal
24th Nov 20234:50 pmRNSNotice of AGM
7th Sep 20237:00 amRNSDirector/PDMR Shareholding
6th Sep 20237:00 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSHolding(s) in Company
31st Aug 202312:46 pmRNSTotal Voting Rights
30th Aug 202311:44 amRNSResult of Meeting
23rd Aug 202311:21 amRNSDirectorate Change
9th Aug 20235:30 pmRNSPublication of Circular, Notice of General Meeting
9th Aug 202310:54 amRNSFundraising, board changes, change of adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.